Ideas and Opinions11 October 2016
    Author, Article, and Disclosure Information

    The uproar about the price of the EpiPen is the latest episode in the controversy over drug pricing that extends back decades. However, the more recent, sustained public outrage and media attention have occurred during a presidential election cycle, which places greater focus on policy prescriptions. A common concern with proposed regulation of drug markets is the extent to which it would reduce the rate of drug innovation and decrease the number of new drugs in the marketplace. But another important consideration is less frequently voiced: How would (or could) policy affect the composition of innovation—the types of drugs that ...